Prognostic factors in patients with advanced neuroendocrine neoplasia treated with radiopeptides (PRRT) - Data from the national registry SEPTRALU

被引：0
|
作者：
Bello, P. [1 ]
Mitjavila Casanovas, M. [2 ]
Jimenez-Fonseca, P. [3 ]
Cabezas Agricola, J. M. [4 ]
Hernando Cubero, J. [5 ]
Garcia Canamaque, L. [6 ]
Gajate, P. [7 ]
Riesco, M. C. [8 ]
Custodio, A. [1 ,9 ]
Miguel Martinez, M. B. [10 ]
Balaguer, D. [11 ]
Carmona-Bayonas, A. [12 ]
机构：
[1] Hosp Univ La Fe, Dept Nucl Med, Valencia, Spain
[2] Hosp Univ Puerta Hierro, Dept Nucl Med, Madrid, Spain
[3] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain
[4] Hosp Univ Santiago Compostela, Santiago De Compostela, Spain
[5] Hosp Univ Val dHebron, Barcelona, Spain
[6] Hosp HM Sanchinarro, Madrid, Spain
[7] Hosp Univ Ramon y Cajal, Madrid, Spain
[8] Hosp Univ Doce Octubre, Madrid, Spain
[9] Hosp Univ La Paz, Madrid, Spain
[10] Hosp Univ Burgos, Burgos, Spain
[11] Hosp Univ Doctor Peset, Valencia, Spain
[12] UMU, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, IMIB, Murcia, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
177lu-dotatate; neuroendocrine tumor; prrt; prognosis; radionuclide therapy; survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H05
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [21] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
    Pinter, M.
    Sieghart, W.
    Hucke, F.
    Graziadei, I.
    Vogel, W.
    Maieron, A.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Matejka, J.
    Stauber, R.
    Buder, R.
    Gruenberger, B.
    Schoeniger-Hekele, M.
    Mueller, C.
    Peck-Radosavljevic, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 949 - 959
  • [22] Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT
    Durmo, Rexhep
    Filice, Angelina
    Fioroni, Federica
    Cervati, Veronica
    Finocchiaro, Domenico
    Coruzzi, Chiara
    Besutti, Giulia
    Fanello, Silvia
    Frasoldati, Andrea
    Versari, Annibale
    CANCERS, 2022, 14 (03)
  • [23] Prognostic value of 18F-FDG PETCT in a large cohort of 495 patients with advanced neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT)
    Zhang, J.
    Liu, Q.
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Niepsch, K.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S89 - S89
  • [24] Radiographic progression in RA patients treated with infliximab, data from the Czech National Registry (attra)
    Pavelka, K
    Vencovsky, J
    Tegzova, D
    Gatterova, J
    Dusek, L
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 263 - 263
  • [25] Current prognostic factors of advanced gastric cancer patients treated with chemotherapy: real world data from a Japanese 12 institutions
    Yamamoto, Shumpei
    Kanzaki, Hiromitsu
    Sakaguchi, Chihiro
    Mouri, Hirokazu
    Tsuzuki, Takao
    Nasu, Junichiro
    Kobayashi, Sayo
    Toyokawa, Tatsuya
    Obayashi, Yuka
    Inoue, Masafumi
    Kato, Ryo
    Matsubara, Minoru
    Kita, Masahide
    Okada, Hiroyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (10) : 928 - 935
  • [26] Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy
    Ishii, H
    Okada, S
    Nose, H
    Yoshimori, M
    Aoki, K
    Okusaka, T
    PANCREAS, 1996, 12 (03) : 267 - 271
  • [27] Clinical characteristics and prognostic factors of patients with gastric neuroendocrine carcinoma treated with radical surgery
    Xu Xuefeng
    Li Jian'ang
    Han Xu
    Shi Chenye
    Jin Dayong
    Lou Wenhui
    CHINESE MEDICAL JOURNAL, 2014, 127 (13) : 2419 - 2422
  • [28] Clinical characteristics and prognostic factors of patients with gastric neuroendocrine carcinoma treated with radical surgery
    Xu Xuefeng
    Li Jian’ang
    Han Xu
    Shi Chenye
    Jin Dayong
    Lou Wenhui
    中华医学杂志（英文版）, 2014, (13) : 2419 - 2422
  • [29] Outcomes of Streptozotocin (STZ)-based chemotherapy (CT) in patients with advanced pancreatic neuroendocrine tumors (pNETs): Data from the Spanish Taskforce of Neuroendocrine and Endocrine Tumors (GETNE) national registry (R-GETNE)
    Esteban-Villarrubia, J.
    Hernando, J.
    Garcia, A.
    Jimenez-Fonseca, P.
    Teule, A.
    Garcia-Carbonero, R.
    Alonso, V
    Molina-Cerrillo, J.
    Paredes B, Garcia
    Herrero G, Crespo
    Capdevila, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 173 - 173
  • [30] Prognostic factors in patients with locally advanced pancreatic cancer treated with concurrent chemoradiotherapy
    Huang, P.
    Chao, Y.
    Li, C.
    Lee, R.
    Chi, K.
    Shiau, C.
    Wang, L.
    Yen, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S269 - S269
12345